Bone Marrow Transplantation News

Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder — for up to 10 years, according to the results of a matched cohort study conducted in Sweden.

A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice President Joe Biden said today during the plenary session of the American Association for Cancer Research Annual Meeting.

NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting.

Reduced-intensity conditioning hematopoietic stem cell transplantation appeared well tolerated and associated with favorable outcomes in selected older patients with acute myeloid leukemia, according to phase 2 study results published in Journal of Clinical Oncology.

Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent affordable generic cancer drugs from entering the market, according to a forum article published in Blood.

NEW ORLEANS — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the American Association for Cancer Research Annual Meeting.

Patients with follicular lymphoma who experienced disease recurrence after autologous stem cell transplant demonstrated benefit from reduced-intensity allogeneic transplant salvage therapy, according to retrospective results.

ASCO will recognize several researchers and scientists during the society’s annual meeting, scheduled for June 3-7 in Chicago.

The FDA today approved defibrotide sodium to treat adults and children who developed hepatic veno-occlusive disease with renal and pulmonary dysfunction after hematopoietic stem cell transplantation.

Clifford A. Hudis, MD, FACP, has been named the next CEO of ASCO.